The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
Chia-Chi Lin
No relevant relationships to disclose
Chih-Hung Hsu
No relevant relationships to disclose
Kai-Yuan Tzen
No relevant relationships to disclose
Jason C. Cheng
No relevant relationships to disclose
Jang-Ming Lee
No relevant relationships to disclose
Hsiu-Po Wang
No relevant relationships to disclose
Pei-Ming Huang
No relevant relationships to disclose
Feng-Ming Hsu
No relevant relationships to disclose
Wei-Wu Chen
No relevant relationships to disclose
Ta-Chen Huang
No relevant relationships to disclose
Ann-Lii Cheng
No relevant relationships to disclose